European Neuropsychopharmacology
Volume 21, Issue 5 , Pages 393-400 , May 2011

Deep brain stimulation of the subthalamic or entopeduncular nucleus attenuates vacuous chewing movements in a rodent model of tardive dyskinesia

  • Meaghan Creed

      Affiliations

    • Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
    • Neuroimaging Research Section, Centre for Addiction and Mental Health, Toronto, ON, Canada
    • ,
  • Clement Hamani

      Affiliations

    • Neuroimaging Research Section, Centre for Addiction and Mental Health, Toronto, ON, Canada
    • Division of Neurosurgery, Toronto Western Hospital, Toronto, ON, Canada
    • ,
  • José N. Nobrega

      Affiliations

    • Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
    • Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    • Department of Psychology, University of Toronto, Toronto, ON, Canada
    • Neuroimaging Research Section, Centre for Addiction and Mental Health, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. Neuroimaging Research Section, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, Canada M5T 1R8. Tel.: +1 416 535 8501x6259; fax: +1 416 979 4739.

Received 11 February 2010 ,Revised 15 June 2010 ,Accepted 23 June 2010.

References 

  1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–375
  2. Alterman RL, Miravite J, Weisz D, Shils JL, Bressman SB, Tagliati M. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology. 2007;69:681–688
  3. Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?. Prog. Neurobiol. 2000;61:525–541
  4. Andreassen OA, Meshul CK, Moore C, Jorgensen HA. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration. Psychopharmacology (Berl). 2001;157:11–19
  5. Andreassen OA, Ferrante RJ, Aamo TO, Beal MF, Jorgensen HA. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience. 2003;122:717–725
  6. Benabid AL, Chabardes S, Torres N, Piallat B, Krack P, Fraix V, et al. Functional neurosurgery for movement disorders: a historical perspective. Prog. Brain Res. 2009;175:379–391
  7. Burger ME, Fachineto R, Alves A, Callegari L, Rocha JB. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res. 2005;1031:202–210
  8. Casey DE. Pathophysiology of antipsychotic drug-induced movement disorders. J. Clin. Psychiatry. 2004;65(Suppl 9):25–28
  9. Clow A, Theodorou A, Jenner P, Marsden CD. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. Eur. J. Pharmacol. 1980;63:135–144
  10. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr. Opin. Psychiatry. 2008;21:151–156
  11. Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S, et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch. Gen. Psychiatry. 2007;64:170–176
  12. Del Sorbo F, Albanese A. Levodopa-induced dyskinesias and their management. J. Neurol. 2008;255(Suppl 4):32–41
  13. Egan MF, Hyde TM, Kleinman JE, Wyatt RJ. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose. Psychopharmacology (Berl). 1995;117:74–81
  14. Egan MF, Ferguson J, Hyde TM. Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements. Pharmacol. Biochem. Behav. 1996;53:401–410
  15. Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology (Berl). 1996;127:337–345
  16. Eltahawy HA, Feinstein A, Khan F, Saint-Cyr J, Lang AE, Lozano AM. Bilateral globus pallidus internus deep brain stimulation in tardive dyskinesia: a case report. Mov. Disord. 2004;19:969–972
  17. Glazer WM. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J. Clin. Psychiatry. 2000;61(Suppl 3):16–21
  18. Glazer WM, Morgenstern H, Doucette JT. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J. Clin. Psychiatry. 1993;54:133–139
  19. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science. 2009;324:354–359
  20. Gunne LM, Growdon J, Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl). 1982;77:134–139
  21. Haddad PM, Sharma SG. Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs. 2007;21:911–936
  22. Hamani C, Moro E. Surgery for other movement disorders: dystonia, tics. Curr. Opin. Neurol. 2007;20:470–476
  23. Kefalopoulou Z, Paschali A, Markaki E, Vassilakos P, Ellul J, Constantoyannis C. A double-blind study on a patient with tardive dyskinesia treated with pallidal deep brain stimulation. Acta Neurol. Scand. 2009;119:269–273
  24. Kitagawa M, Murata J, Kikuchi S, Sawamura Y, Saito H, Sasaki H, et al. Deep brain stimulation of subthalamic area for severe proximal tremor. Neurology. 2000;55:114–116
  25. Klawans HL, Rubovits R. An experimental model of tardive dyskinesia. J. Neural Transm. 1972;33:235–246
  26. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 2006;21(Suppl 14):S290–S304
  27. Kosel M, Sturm V, Frick C, Lenartz D, Zeidler G, Brodesser D, et al. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J. Psychiatr. Res. 2007;41:801–803
  28. Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol. 2002;1:225–231
  29. Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol. 2002;1:225–231
  30. McIntyre CC, Savasta M, Walter BL, Vitek JL. How does deep brain stimulation work? Present understanding and future questions. J. Clin. Neurophysiol. 2004;21:40–50
  31. Moro E, Esselink RJ, Xie J, Hommel M, Benabid AL, Pollak P. The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 2002;59:706–713
  32. Murata J, Kitagawa M, Uesugi H, Saito H, Iwasaki Y, Kikuchi S, et al. Electrical stimulation of the posterior subthalamic area for the treatment of intractable proximal tremor. J. Neurosurg. 2003;99:708–715
  33. Murata T, Maruoka N, Omata N, Takashima Y, Igarashi K, Kasuya F, et al. Effects of haloperidol and its pyridinium metabolite on plasma membrane permeability and fluidity in the rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31:848–857
  34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press; 1986;
  35. Remington G. Tardive dyskinesia: eliminated, forgotten, or overshadowed?. Curr. Opin. Psychiatry. 2007;20:131–137
  36. Sako W, Goto S, Shimazu H, Murase N, Matsuzaki K, Tamura T, et al. Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia. Mov. Disord. 2008;23:1929–1931
  37. Schrader C, Peschel T, Petermeyer M, Dengler R, Hellwig D. Unilateral deep brain stimulation of the internal globus pallidus alleviates tardive dyskinesia. Mov. Disord. 2004;19:583–585
  38. Soares KV, McGrath JJ. The treatment of tardive dyskinesia—a systematic review and meta-analysis. Schizophr. Res. 1999;39:1–16Discussion 17–18
  39. Stoessl AJ, Rajakumar N. Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat. Synapse. 1996;24:256–261
  40. Sun B, Chen S, Zhan S, Le W, Krahl SE. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir. Suppl. 2007;97:207–214
  41. Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology (Berl). 1990;102:474–478
  42. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am. J. Psychiatry. 1998;155:1207–1213
  43. Turrone P, Remington G, Nobrega JN. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?. Neurosci. Biobehav. Rev. 2002;26:361–380
  44. Turrone P, Remington G, Kapur S, Nobrega JN. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats. Psychopharmacology (Berl). 2003;165:166–171
  45. Vitek JL. Mechanisms of deep brain stimulation: excitation or inhibition. Mov. Disord. 2002;17(Suppl 3):S69–S72
  46. Volkmann J. Deep brain stimulation for the treatment of Parkinson's disease. J. Clin. Neurophysiol. 2004;21:6–17
  47. Waddington JL. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berl). 1990;101:431–447

PII: S0924-977X(10)00139-2

doi: 10.1016/j.euroneuro.2010.06.012

European Neuropsychopharmacology
Volume 21, Issue 5 , Pages 393-400 , May 2011

Article Tools

* Image Usage & Resolution